<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Several biomarkers have been individually associated with vascular brain injury, but no prior study has explored the simultaneous association of a biologically plausible panel of biomarkers with the incidence of <z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> and the prevalence of subclinical brain injury </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS AND RESULTS: In 3127 <z:hpo ids='HP_0001297'>stroke</z:hpo>-free Framingham offspring (age, 59±10 years; 54% female), we related a panel of 8 biomarkers assessing <z:mp ids='MP_0001845'>inflammation</z:mp> (C-reactive protein), hemostasis (D-dimer and plasminogen activator inhibitor-1), neurohormonal activity (<z:chebi fb="0" ids="27584,30834">aldosterone</z:chebi>-to-renin ratio, B-type natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi>, and N-terminal proatrial natriuretic <z:chebi fb="7" ids="16670">peptides</z:chebi>), and endothelial function (<z:chebi fb="0" ids="17230">homocysteine</z:chebi> and urinary albumin/<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio) measured at the sixth examination (1995-1998) to risk of incident <z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In a subset of 1901 participants with available brain magnetic resonance imaging (1999-2005), we further related these biomarkers to total cerebral brain volume, covert brain <z:mpath ids='MPATH_124'>infarcts</z:mpath>, and large white-matter hyperintensity volume </plain></SENT>
<SENT sid="3" pm="."><plain>During a median follow-up of 9.2 years, 130 participants experienced incident <z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In multivariable analyses adjusted for <z:hpo ids='HP_0001297'>stroke</z:hpo> risk factors, the biomarker panel was associated with incident <z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> and with total cerebral brain volume (P&lt;0.05 for both) but not with covert brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> or white-matter hyperintensity volume (P&gt;0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>In backward elimination analyses, higher log-B-type natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi> (hazard ratio, 1.39 per 1-SD increment; P=0.002) and log-urinary albumin/<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio (hazard ratio, 1.31 per 1-SD increment; P=0.004) were associated with increased risk of <z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> and improved risk prediction compared with the Framingham <z:hpo ids='HP_0001297'>Stroke</z:hpo> Risk Profile alone; when the &lt;5%, 5% to 15%, or &gt;15% 10-year risk category was used, the net reclassification index was 0.109 (P=0.037) </plain></SENT>
<SENT sid="6" pm="."><plain>Higher C-reactive protein (β=-0.21 per 1-SD increment; P=0.008), D-dimer (β=-0.18 per 1-SD increment; P=0.041), total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (β=-0.21 per 1-SD increment; P=0.005), and urinary albumin/<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio (β=-0.15 per 1-SD increment; P=0.042) were associated with lower total cerebral brain volume </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: In a middle-aged community sample, we identified multiple biomarkers that were associated with clinical and subclinical vascular brain injury and could improve risk stratification </plain></SENT>
</text></document>